HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[FTLD/ALS as TDP-43 proteinopathies].

Abstract
Frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) often coexist in the same patients: FTLD/MND. However, it is unclear whether FTLD/MND can be distinguished from ALS or FTLD. TAR DNA binding protein 43 KDa (TDP-43) has been identified as the major component of the ubiquitin-positive inclusion bodies in ALS, FTLD, and FTLD/MND. On the basis of this finding, a new concept of neurodegenerative disorders, namely TDP-43 proteinopathy, has been proposed for these disorders. In ALS, more than 30 mutations of the TDP-43 gene have been identified. The clinical features and neuropathological findings of ALS with TDP-43 mutation are identical to those of sporadic ALS. Therefore, TDP-43 plays a primary role in the pathogenesis of ALS. In contrast, only few patients with FTLD phenotype have TDP-43 mutations. Therefore, we have speculated that TDP-43 does not play a primary role in the pathogenesis of FTLD. The analysis of distribution of TDP-43 inclusion bodies in ALS patients revealed that ALS has two subtypes: (1) limited in the motor neuron system and (2) extended into the frontotemporal lobe. Additionally, causative genes of familial FTLD/MND have not been mapped to TDP-43. These results suggest that FTLD/MND is a disease distinct from FTLD and ALS.
AuthorsTomohiko Ishihara, Yuko Ariizumi, Atsushi Shiga, Akio Yokoseki, Tatsuya Sato, Yasuko Toyoshima, Akiyoshi Kakita, Hitoshi Takahashi, Masatoyo Nishizawa, Osamu Onodera
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 50 Issue 11 Pg. 1022-4 (Nov 2010) ISSN: 1882-0654 [Electronic] Japan
PMID21921552 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • DNA-Binding Proteins
Topics
  • Amyotrophic Lateral Sclerosis (classification, pathology, physiopathology)
  • DNA-Binding Proteins (genetics, physiology)
  • Frontotemporal Lobar Degeneration (pathology, physiopathology)
  • Humans
  • Inclusion Bodies (metabolism)
  • Mutation
  • TDP-43 Proteinopathies (pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: